CT-scanner
RadiationAfter a clinical exam, patient have a CT-scanner to check any cerebral haemorrhage.
NCT Number: NCT03687528
At the emergencies rooms, patients with head trauma meeting one of the NICE criteria, which include antiplatelet inhibitors treatment, are considered as patients with a risk of cerebral haemorrage and are taken systematically for a CT-scanner.
However, there are more and more antiplatelet inhibitor's patient with minor head injury traumas seen at the emergencies room and the efficiency of this NICE criteria is controversial on litterature.
This study aims to determine that the absence of no other NICE criteria than antiplatelet inhibitors is a sufficient condition to eliminate a cerebral haemorrhage for patients with head injury traumas, and conversely, that antiplatelet inhibitors treatment would not be by itself an indication for a CT-scanner.
Interested in participating?
Request Info18 year and older
All sexes
Observational
CHU d'Angers, Angers, France
Head injuries are a frequent reason for emergency services, and according to studies, they represent between 5% and 10% of patients treated in emergencies. Among them, 90% are minor head injury traumas. NICE criteria has been defined to establish patients who need a CT-scanner because of a risk of cerebral haemorrhage.
NICE criteria include several conditions including taking antiplatelet inhibitors. However, the real risk of cerebral haemorrhage for theses cases is controversial in litterature. In parallel, more and more patients undergoing antiplatelet inhibitor's treatment are seen in emergencies after a head injury trauma.
In routine protocol at the emergency rooms, these patients are seen for a clinical exam and next submitted to a CT-scanner. If the clinician can't detect a cerebral haemorrage, the patient will return at home.
This study aims to determine that the absence of no other NICE criteria than antiplatelet inhibitors treatment is a sufficient condition to eliminate a cerebral haemorrhage for patients with head injury traumas, and conversely, that antiplatelet inhibitors treatment would not be by itself an indication for a CT-scanner.
This is a diagnostic, case-only, prospective, multicenter study with a blinded primary outcome measure assessment.
As described in routine protocol, in this study antiplatelet inhibitor's patients with head injury trauma will be seen for a clinical exam and next submitted to a CT-scanner. After a month, patient will be called by the clinical center to ask about morbidity and mortality. Especially, clinicans will report on the emergence of a cerebral haemorrhage during this month.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After a clinical exam, patient have a CT-scanner to check any cerebral haemorrhage.
Time frame: 1 day
Cerebral haemorrhage seen at the CT-scanner.
Time frame: 1 month
Neurosurgeries' rate after one month
Time frame: 1 month
Existence of a cerebral haemorrhage associated to death
Time frame: 1 month
Existence of a cerebral haemorrhage associated to neurosurgery
Time frame: 1 month
Existence of a cerebral haemorrhage associated to hospitalization with more than 24h of intubation
Time frame: 1 month
Existence of a cerebral haemorrhage associated to more than 2 nights at hospital
Time frame: 1 month
Death rate after one month
Contact information is provided by the study sponsor or research team.
Marie-Laure GERVAIS
CONTACT
Paul-Georges REUTER, Pr
CONTACT
Rennes University Hospital
Other
Platelet Inhibitor Treated Patients With Head Injury Trauma Without Any Clinical Symptoms of Cerebral Haemorrhage (NICE Criteria) : is the CT-scan Mandatory ?
Acronym: TCAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03870867
Brain Diseases, Cardiovascular Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT07339319
Head Injury Trauma
Bologna, Italy
View Trial DetailsNCT06370520
Brain Concussion, Brain Diseases
Sacramento, California, United States
View Trial DetailsNCT06851234
Brain Concussion, Brain Diseases
Greenvale, New York, United States
View Trial Details